275 related articles for article (PubMed ID: 24023270)
1. Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation.
Oshima T; Kawahara S; Ueda M; Kawakami Y; Tanaka R; Okazaki T; Misumi Y; Obayashi K; Yamashita T; Ohya Y; Ihse E; Shinriki S; Tasaki M; Jono H; Asonuma K; Inomata Y; Westermark P; Ando Y
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):740-6. PubMed ID: 24023270
[TBL] [Abstract][Full Text] [Related]
2. Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.
Obayashi K; Ueda M; Oshima T; Kawahara S; Misumi Y; Yamashita T; Jono H; Yazaki M; Kametani F; Ikeda S; Ohya Y; Asonuma K; Inomata Y; Ando Y
BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22907857
[TBL] [Abstract][Full Text] [Related]
3. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
[TBL] [Abstract][Full Text] [Related]
4. Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.
Tasaki M; Ueda M; Obayashi K; Koike H; Kitagawa K; Ogi Y; Jono H; Su Y; Suenaga G; Oshima T; Misumi Y; Yoshida M; Yamashita T; Sobue G; Ando Y
Int J Cardiol; 2013 Dec; 170(1):69-74. PubMed ID: 24182678
[TBL] [Abstract][Full Text] [Related]
5. Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy.
Tsuchiya-Suzuki A; Yazaki M; Sekijima Y; Kametani F; Ikeda S
Amyloid; 2013 Sep; 20(3):156-63. PubMed ID: 23826783
[TBL] [Abstract][Full Text] [Related]
6. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of familial amyloid polyneuropathy].
Adams D; Samuel D; Slama M
Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949
[TBL] [Abstract][Full Text] [Related]
8. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
Berg I; Thor S; Hammarström P
Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
[TBL] [Abstract][Full Text] [Related]
9. Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver.
Takei Y; Gono T; Yazaki M; Ikeda S; Ikegami T; Hashikura Y; Miyagawa S; Hoshii Y
Liver Transpl; 2007 Feb; 13(2):215-8. PubMed ID: 17029284
[TBL] [Abstract][Full Text] [Related]
10. Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers.
Sousa MM; Ferrão J; Fernandes R; Guimarães A; Geraldes JB; Perdigoto R; Tomé L; Mota O; Negrão L; Furtado AL; Saraiva MJ
Lab Invest; 2004 Jul; 84(7):865-73. PubMed ID: 15122304
[TBL] [Abstract][Full Text] [Related]
11. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
12. [Familial amyloid polyneuropathy: clinicopathological aspects].
Koike H; Sobue G
Brain Nerve; 2014 Jul; 66(7):749-62. PubMed ID: 24998820
[TBL] [Abstract][Full Text] [Related]
13. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy.
Koike H; Misu K; Sugiura M; Iijima M; Mori K; Yamamoto M; Hattori N; Mukai E; Ando Y; Ikeda S; Sobue G
Neurology; 2004 Jul; 63(1):129-38. PubMed ID: 15249622
[TBL] [Abstract][Full Text] [Related]
14. Familial amyloidotic polyneuropathy and transthyretin.
Nagasaka T
Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
[TBL] [Abstract][Full Text] [Related]
15. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
[TBL] [Abstract][Full Text] [Related]
16. [Familial amyloid polyneuropathy].
Yamashita T; Ando Y; Uchino M
Brain Nerve; 2011 Jun; 63(6):583-95. PubMed ID: 21613661
[TBL] [Abstract][Full Text] [Related]
17. Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.
Sousa MM; Fernandes R; Palha JA; Taboada A; Vieira P; Saraiva MJ
Am J Pathol; 2002 Nov; 161(5):1935-48. PubMed ID: 12414539
[TBL] [Abstract][Full Text] [Related]
18. Late-onset familial amyloid polyneuropathy in Japan.
Koike H; Sobue G
Amyloid; 2012 Jun; 19 Suppl 1():55-7. PubMed ID: 22506939
[TBL] [Abstract][Full Text] [Related]
19. Clusterin regulates transthyretin amyloidosis.
Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
[TBL] [Abstract][Full Text] [Related]
20. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
